Cancer

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with Carnegie-Mellon University (CMU) for an…

2 hours ago

Toxin-to-Treasure: Chonnam National University Scientists Use Engineered Enzyme to Turn Formaldehyde Pollutant into High-Value Chemical

The study demonstrates engineered aldolase-catalyzed regioselective conversion of formaldehyde into L-glyceraldehyde JEOLLANAM-DO PROVINCE, South Korea, Dec. 22, 2025 /PRNewswire/ --…

8 hours ago

datma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Development

The two companies will explore how datma's federated ecosystem can support Rhythm Biosciences' diagnostic development efforts as they shape a…

8 hours ago

OsteoCentric Technologies Appoints Matthew Collier to Board of Directors

AUSTIN, Texas, Dec. 22, 2025 /PRNewswire/ -- OsteoCentric Technologies announced today the appointment of Matthew Collier to its Board of Directors,…

8 hours ago

AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular…

11 hours ago

Ovation Science Sees Expanded Opportunities for Its Topical Products Following U.S. Cannabis Rescheduling

VANCOUVER, BC AND LAS VEGAS, NV / ACCESS Newswire / December 22, 2025 / Ovation Science Inc. (CSE:OVAT)(OTC PINK:OVATF) ("Ovation"…

11 hours ago

Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist,…

11 hours ago

Imviva Biotech Announces First Patient Dosed in Phase 1b/2 TENACITY-01 Trial of CTD402 CAR-T Cell Therapy

Patient achieved complete remission and well-tolerated safety profile, advancing path to Phase 2BOSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Imviva…

11 hours ago

Vivos Inc Summarzes Preogress in its Animal Therapy Division

Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported an 800% year-over-year increase…

11 hours ago

CoRegen Appoints Globally Recognized Surgeon-Scientist Bert O’Malley Jr. to its Board of Directors

HOUSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) -- CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some…

11 hours ago